Atrial fibrillation : Clinical usefulness of systematic screening
DISEASE INTERVENTION COMPARISON RESULTS
Lancet. 2021 Aug 27:S0140-6736(21)01698-6. doi: 10.1016/S0140-6736(21)01698-6 Randomized Controlled Trial, Multicenter Study
IN atrial fibrillation, asymptomatic, older people, previous stroke, ischemic, embolic, or at risk of stroke The Use of
systematic screening for atrial fibrillation at 75 years, using an implantable loop recorder, followed by oral anticoagulation if AF detected
As Diagnostic Tool
Is better Than
screening for atrial fibrillation only if symptoms
To modify, at 5 years, stroke or systemic embolism: 4.5% loop recorder VS 5.6% controls, p=0.11
Lancet. 2021 Aug 27:S0140-6736(21)01637-8. doi: 10.1016/S0140-6736(21)01637-8 Randomized Controlled Trial
IN atrial fibrillation, asymptomatic, older people, primary prevention of stroke, ischemic, embolic The Use of
systematic screening for atrial fibrillation at 75 years, using intermittent ECGs for 14 days, followed by oral anticoagulation if AF detected
As Diagnostic Tool
Is better Than
screening for atrial fibrillation only if symptoms
To slighty reduce, at 7 years, combined embolic events, severe bleeding or death: 5.5 events VS 5.7 per 100 person-years